HomeCompareBBUS vs JNJ

BBUS vs JNJ: Dividend Comparison 2026

BBUS yields 1.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BBUS wins by $1.3K in total portfolio value
10 years
BBUS
BBUS
● Live price
1.14%
Share price
$116.74
Annual div
$1.34
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$123.18
Full BBUS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BBUS vs JNJ

📍 BBUS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBBUSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BBUS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BBUS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BBUS
Annual income on $10K today (after 15% tax)
$97.21/yr
After 10yr DRIP, annual income (after tax)
$104.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $598.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BBUS + JNJ for your $10,000?

BBUS: 50%JNJ: 50%
100% JNJ50/50100% BBUS
Portfolio after 10yr
$20.7K
Annual income
$475.48/yr
Blended yield
2.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BBUS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BBUS buys
0
JNJ buys
0
No recent congressional trades found for BBUS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBBUSJNJ
Forward yield1.14%3.36%
Annual dividend / share$1.34$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.3K$20.0K
Annual income after 10y$123.18$827.78
Total dividends collected$1.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BBUS vs JNJ ($10,000, DRIP)

YearBBUS PortfolioBBUS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,814$114.37$10,676$355.77+$138.00BBUS
2$11,687$115.59$11,407$389.39+$280.00BBUS
3$12,622$116.75$12,198$426.53+$424.00BBUS
4$13,623$117.84$13,056$467.62+$567.00BBUS
5$14,696$118.87$13,987$513.12+$709.00BBUS
6$15,844$119.84$14,998$563.56+$846.00BBUS
7$17,074$120.75$16,098$619.52+$976.00BBUS
8$18,391$121.61$17,295$681.69+$1.1KBBUS
9$19,801$122.42$18,599$750.82+$1.2KBBUS
10$21,310$123.18$20,022$827.78+$1.3KBBUS

BBUS vs JNJ: Complete Analysis 2026

BBUSStock

The underlying index is a free float adjusted market capitalization weighted index which consists of equity securities primarily traded in the United States. The underlying index targets 85% of those stocks by market capitalization, and primarily includes large- and mid-cap companies. The fund will invest at least 80% of its assets in securities included in the underlying index.

Full BBUS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BBUS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BBUS vs SCHDBBUS vs JEPIBBUS vs OBBUS vs KOBBUS vs MAINBBUS vs ABBVBBUS vs MRKBBUS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.